Daily non-political popular news in brief.

Three Molecular Triggers Threaten Leukemia Patients

The road to better treatment for the most common form of adult leukemia will require blocking multiple molecular pathways that fuel the disease, researchers at the University of Texas M. D. Anderson Cancer Center report in the Oct. 1 edition of the journal Blood.

Read more »

Keywords: molecular, triggers, threaten, leukemia, patients, trigger, patient

« Previous | Next »

Similar news on "Three Molecular Triggers Threaten Leukemia Patients":

1. Pancreatic cancer vaccine halts progression of disease in some patients
   04-17-2007 · EurekAlert!
   A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
   Similar news · Read more »
   
2. Researchers identify cells that make relapse inevitable in acute lymphoblastic leukemia
   11-09-2006 · EurekAlert!
   Scientists in Australia have discovered that in acute lymphoblastic leukemia (ALL) there are "good" and "evil" clones of the same type of ALL cell. The "evil" cells are clones that have a pre-existing resistance to drugs used for treating ALL, and their presence in a patient means that person will inevitably relapse after chemotherapy, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
   Similar news · Read more »
   
3. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
4. New genomic tests guide choice of chemotherapy in cancer patients
   10-22-2006 · EurekAlert!
   Scientists at Duke University's Institute for Genome Sciences & Policy have developed a panel of genomic tests that analyzes the unique molecular traits of a cancerous tumor and determines which chemotherapy will most aggressively attack that patient's cancer.
   Similar news · Read more »
   
5. Molecular detectors may refine cancer treatment
   07-19-2007 · EurekAlert!
   University of Florida scientists used short, single strands of genetic material called aptamers to bind to cells and molecules associated with leukemia, finding evidence that slight molecular differences can exist in patient samples.
   Similar news · Read more »
   
6. Novel test identifies leukemia patients likely to respond to new therapy
   02-20-2007 · EurekAlert!
   Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
   Similar news · Read more »
   
7. What's going on in the body? Advanced time-of-flight PET takes a superior 'look'
   06-04-2007 · EurekAlert!
   Moving from computer simulation to patient images, researchers are now demonstrating the benefits that time-of-flight/PET imaging can provide for cancer patients. The result? Superior images and shorter patient scan times for starters, according to a study released at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals, June 2-6 in Washington, D.C.
   Similar news · Read more »
   
8. Mouse tests predict drug response in relapsing pancreatic cancer patients
   10-11-2006 · EurekAlert!
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
9. Remote device allows cardiologist to monitor patients daily at their homes
   01-31-2007 · EurekAlert!
   An easy-to-use in home monitoring device for patients is changing the way doctors monitor the health of patients with implanted defibrillators. Rush University Medical Center is participating in a pilot study of the Latitude Patient Management system to determine if the wireless home monitoring system can decrease hospitalizations for heart failure.
   Similar news · Read more »
   
10. Gene patenting -- steep cost for health care and patients
    05-07-2007 · EurekAlert!
    The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
    Similar news · Read more »